Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Celgosivir hydrochloride by 60 Degrees Pharmaceuticals for Respiratory Syncytial Virus (RSV) Infections: Likelihood of Approval
Celgosivir hydrochloride is under clinical development by 60 Degrees Pharmaceuticals and currently in Phase I for Respiratory Syncytial Virus (RSV)...